Document is current

Article History

Accepted: 7 June 2021

First Online: 1 July 2021

Declarations

:

: Funding for this study was provided by Alexion Pharmaceuticals, Inc.

: Peter Chen, Katerina Anokhina, and Yan Wang are employees of, and may own stocks/options in, Alexion Pharmaceuticals, Inc. Kate Williams, Daniel Aggio, and Andrew J. Lloyd are employees of Acaster Lloyd Consulting Ltd.

: All study materials were submitted to the Western Institutional Review Board, a central institutional review board in the USA, for ethical review. The Western Institutional Review Board reviewed the documents and declared the study exempt from ethical review (tracking number: 2597751-44448981).

: Not applicable.

: All participants consented to participation in the study.

: All participants consented to their data being incorporated in the study's findings in an anonymized manner.

: All authors contributed to the study conception and design as well as interpretation of the data. The DCE survey was developed by KW and AJL with input from all authors. The analyses were performed by KW, DA, and AJL. All co-authors have revised all manuscript drafts critically and have approved the final version of the manuscript. All co-authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work were appropriately addressed and resolved.

: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.